Earlier this year, mounting concerns over the potential health effects of triclosan, a common antimicrobial ingredient, prompted Minnesota to ban the germ-killer from consumer soaps statewide starting in 2017. Are these concerns warranted? An article in Chemical & Engineering News (C&EN), the weekly news magazine of the American Chemical Society, investigates.
Jyllian Kemsley, a senior editor at C&EN, notes that when it was first patented, triclosan was used as an antimicrobial agent in health care settings. It was a much more benign option as a surgical scrub than the biocides used at the time. But then, it hit the mass market. Now, companies add the compound to deodorants, toothpastes, cosmetics, detergents, cutting boards, toys, carpets and many other everyday products. As a result, in one study, triclosan was found in 75 percent of the urine samples from participants. The question is, what does this mean?
The article notes that the answer is not simple. The Environmental Protection Agency has concluded that the chances triclosan will cause problems for most people are probably minimal. However, those who aren't able to metabolize triclosan could end up with higher levels of the compound in their blood. In animal studies, the antimicrobial disrupts the heart, muscles and hormones.
These results don't bode well for the most vulnerable among us: fetuses and breastfeeding babies. Triclosan's potential to contribute to antibiotic resistance is also a cause for concern. It's not even clear if the substance reduces infections. All of these considerations and more have led the Food and Drug Administration to propose regulations that would require manufacturers to show a clinical benefit to adding the controversial compound to consumer products.
Source: American Chemical Society
Tackling Health Care-Associated Infections: SHEA’s Bold 10-Year Research Plan to Save Lives
December 12th 2024Discover SHEA's visionary 10-year plan to reduce HAIs by advancing infection prevention strategies, understanding transmission, and improving diagnostic practices for better patient outcomes.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.